Cargando…
Arylamine N-Acetyltransferase Is Required for Synthesis of Mycolic Acids and Complex Lipids in Mycobacterium bovis BCG and Represents a Novel Drug Target
Mycolic acids represent a major component of the unique cell wall of mycobacteria. Mycolic acid biosynthesis is inhibited by isoniazid, a key frontline antitubercular drug that is inactivated by mycobacterial and human arylamine N-acetyltransferase (NAT). We show that an in-frame deletion of Mycobac...
Autores principales: | Bhakta, Sanjib, Besra, Gurdyal S., Upton, Anna M., Parish, Tanya, Sholto-Douglas-Vernon, Carolyn, Gibson, Kevin J.C., Knutton, Stuart, Gordon, Siamon, daSilva, Rosangela P., Anderton, Matthew C., Sim, Edith |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211905/ https://www.ncbi.nlm.nih.gov/pubmed/15117974 http://dx.doi.org/10.1084/jem.20031956 |
Ejemplares similares
-
Arylamine N-Acetyltransferases in Mycobacteria
por: Sim, Edith, et al.
Publicado: (2008) -
Kinetic characterisation of arylamine N-acetyltransferase from Pseudomonas aeruginosa
por: Westwood, Isaac M, et al.
Publicado: (2007) -
Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding
por: Laurieri, Nicola, et al.
Publicado: (2014) -
Enhanced immunogenicity of Mycobacterium bovis BCG through CRISPRi mediated depletion of AftC
por: Madduri, Bala T.S.A., et al.
Publicado: (2022) -
Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery
por: Sim, E, et al.
Publicado: (2014)